PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children\'s Hospital, Seattle, WA, United States. Electronic address: kelsie.pearson@seattlechildrens.org.\', \'Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children\'s Hospital, Seattle, WA, United States; Department of Pediatrics, University of Washington, Seattle, WA, United States; Department of Biostatistics, University of Washington, Seattle, WA, United States.\', \'Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children\'s Hospital, Seattle, WA, United States; Department of Medicine, University of Washington, Seattle, WA, United States.\', \'Division of Pediatric Pulmonology, University of North Carolina, Chapel Hill, NC, United States.\', \'Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children\'s Hospital, Seattle, WA, United States.\', \'Cystic Fibrosis Foundation, Bethesda, MD, United States.\', \'Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, Missouri, United States.\', \'Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children\'s Hospital, Seattle, WA, United States; Department of Pediatrics, University of Washington, Seattle, WA, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1569-1993(20)30939-510.1016/j.jcf.2020.12.007
?:hasPublicationType
?:journal
  • Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
is ?:pmid of
?:pmid
?:pmid
  • 33349583
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all